Volume 87 Issue 14 | p. 17 | Concentrates
Issue Date: April 6, 2009

Solvay Mulls Options For Drug Business

Department: Business

Solvay is holding discussions with third parties as it analyzes options for its pharmaceutical business. The business had sales last year of almost $3.6 billion, about 28% of Solvay's total sales. After AkzoNobel's 2007 sale of its drug business to Schering-Plough, Solvay is one of the last big European companies with businesses that span pharmaceuticals, chemicals, and plastics.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment